• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染后,在未控制的糖尿病患者中因滥用糖皮质激素和抗生素导致的致命性毛霉病

Fatal Mucormycosis Post COVID-19 Infection in Uncontrolled Diabetes with Misuse of Glucocorticoids and Antibiotics.

作者信息

Hamed Heba, Madia Raed, Ladadweh Hosniyeh, Falana Hiba, AbuKhalil Abdallah Damin

机构信息

Palestine Medical Complex, Ministry of Health, Ramallah, Palestine.

Pharmacy Department, Faculty of Pharmacy, Nursing and Health Professions, Birzeit University, Birzeit, Palestine.

出版信息

Infect Drug Resist. 2022 Mar 18;15:1121-1126. doi: 10.2147/IDR.S356465. eCollection 2022.

DOI:10.2147/IDR.S356465
PMID:35330787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8939863/
Abstract

BACKGROUND

Mucormycosis is a fulminant and rapidly progressing fungal infection associated with a high mortality rate. Mucormycosis is primarily seen in immunocompromised patients, especially those with uncontrolled diabetes mellitus (DM), and recently in coronavirus disease 2019 (COVID-19) patients.

CASE PRESENTATION

In this case report, we present a rare case of fatal mucormycosis in Palestine. A 34-year-old Palestinian female patient presented to the emergency department one-month post-COVID-19 infection with left facial pain. During her hospital stay, she deteriorated, with a random blood sugar level of 400 mg/dl and a hemoglobin A1c of 18% with metabolic acidosis and the appearance of swelling and black eschar on her left side of her face. Finally, she was diagnosed with mucormycosis and expired two days later.

CONCLUSION

In this unfortunate case report of mucormycosis, severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection, delayed diagnosis, misuse of corticosteroids, inappropriate use of antibiotics, and uncontrolled diabetes with ketoacidosis contributed to patient mortality and fatality. Therefore, appropriate patient assessment, rapid diagnosis, and selection of appropriate treatment are important and lifesaving.

摘要

背景

毛霉病是一种暴发性且进展迅速的真菌感染,死亡率很高。毛霉病主要见于免疫功能低下的患者,尤其是那些糖尿病控制不佳的患者,最近在2019冠状病毒病(COVID-19)患者中也有发现。

病例报告

在本病例报告中,我们呈现了巴勒斯坦一例罕见的致命性毛霉病病例。一名34岁的巴勒斯坦女性患者在感染COVID-19一个月后因左侧面部疼痛就诊于急诊科。在住院期间,她病情恶化,随机血糖水平为400mg/dl,糖化血红蛋白为18%,伴有代谢性酸中毒,左侧面部出现肿胀和黑色焦痂。最终,她被诊断为毛霉病,并于两天后死亡。

结论

在这份不幸的毛霉病病例报告中,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染、诊断延误、皮质类固醇的不当使用、抗生素的不合理使用以及伴有酮症酸中毒的糖尿病控制不佳导致了患者的死亡。因此,对患者进行适当评估、快速诊断并选择合适的治疗方法非常重要且能挽救生命。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a2f/8939863/dfe291cfb1be/IDR-15-1121-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a2f/8939863/71fc1d445bc6/IDR-15-1121-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a2f/8939863/dcb8931a302d/IDR-15-1121-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a2f/8939863/dfe291cfb1be/IDR-15-1121-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a2f/8939863/71fc1d445bc6/IDR-15-1121-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a2f/8939863/dcb8931a302d/IDR-15-1121-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a2f/8939863/dfe291cfb1be/IDR-15-1121-g0003.jpg

相似文献

1
Fatal Mucormycosis Post COVID-19 Infection in Uncontrolled Diabetes with Misuse of Glucocorticoids and Antibiotics.新冠病毒感染后,在未控制的糖尿病患者中因滥用糖皮质激素和抗生素导致的致命性毛霉病
Infect Drug Resist. 2022 Mar 18;15:1121-1126. doi: 10.2147/IDR.S356465. eCollection 2022.
2
Unnecessary Use of Corticosteroids for managing early mild symptoms of COVID-19 may lead to Rhino-ortibal-cerebral mucormycosis in Patients with Diabetes - a case series from Lahore, Pakistan.使用皮质类固醇治疗COVID-19早期轻度症状可能导致糖尿病患者发生鼻眶脑毛霉菌病——来自巴基斯坦拉合尔的病例系列
Ther Adv Infect Dis. 2022 May 6;9:20499361221097417. doi: 10.1177/20499361221097417. eCollection 2022 Jan-Dec.
3
When Worlds Collide: An Interesting Case of Rhinocerebral Mucormycosis Exacerbated by COVID-19 and Diabetic Ketoacidosis Complicated by Intraorbital Hematoma.当世界碰撞:一例因新冠病毒病和糖尿病酮症酸中毒加重、并发眶内血肿的鼻脑型毛霉菌病的有趣病例
Cureus. 2022 Jan 13;14(1):e21203. doi: 10.7759/cureus.21203. eCollection 2022 Jan.
4
[Clinical case of mucormycosis in patient COVID-19. Case report].[新型冠状病毒肺炎患者毛霉菌病临床病例。病例报告]
Ter Arkh. 2022 Dec 26;94(11):1320-1325. doi: 10.26442/00403660.2022.11.201942.
5
Mucormycosis, one month after recovery from COVID-19: A case report.新型冠状病毒肺炎康复后一个月发生的毛霉病:一例报告
Ann Med Surg (Lond). 2022 Jun;78:103911. doi: 10.1016/j.amsu.2022.103911. Epub 2022 Jun 4.
6
Dexamethasone Induced Sino-Orbital Mucormycosis In a Patient Infected With COVID-19.新冠肺炎感染患者中地塞米松诱发的鼻窦眼眶毛霉菌病
Caspian J Intern Med. 2022;13(Suppl 3):277-280. doi: 10.22088/cjim.13.0.277.
7
COVID-19 Coinfection With Mucormycosis in a Diabetic Patient.一名糖尿病患者新冠病毒感染合并毛霉菌病
Cureus. 2021 Jun 22;13(6):e15820. doi: 10.7759/cureus.15820. eCollection 2021 Jun.
8
Rhino-Orbital Mucormycosis After COVID-19 Infection in a Patient With Non-Hodgkin's Lymphoma.一名非霍奇金淋巴瘤患者感染新冠病毒后发生鼻眶毛霉菌病
Cureus. 2022 Feb 22;14(2):e22485. doi: 10.7759/cureus.22485. eCollection 2022 Feb.
9
Mucormycosis of Paranasal Sinuses of Odontogenic Origin Post COVID19 Infection: A Case Series.新冠病毒感染后牙源性鼻窦毛霉菌病:病例系列
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3437-3441. doi: 10.1007/s12070-021-02638-1. Epub 2021 Jun 17.
10
Two Uncommon Presentations of COVID-19-Associated Mucormycosis.新型冠状病毒肺炎相关毛霉菌病的两种罕见表现
Cureus. 2022 Jan 14;14(1):e21229. doi: 10.7759/cureus.21229. eCollection 2022 Jan.

引用本文的文献

1
Natural polymer based drug-loaded hydrogel platform for comprehensive care of acute spinal cord injury.基于天然聚合物的载药水凝胶平台用于急性脊髓损伤的综合护理
Mater Today Bio. 2025 Jan 7;31:101464. doi: 10.1016/j.mtbio.2025.101464. eCollection 2025 Apr.
2
Proven Cutaneous Mucormycosis in a COVID-19 Patient: A Case Report and Literature Review.一名新冠肺炎患者确诊皮肤毛霉菌病:病例报告与文献综述
Iran J Pathol. 2024 Spring;19(2):259-268. doi: 10.30699/IJP.2024.2006768.3143. Epub 2024 Feb 15.
3
A Systematic Evaluation of Risk Predictors for COVID-19 Sequelae.

本文引用的文献

1
Mucormycosis: early treatment is the key to survival.
Med J Aust. 2021 Nov 1;215(9):401-403. doi: 10.5694/mja2.51290. Epub 2021 Oct 9.
2
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病:全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
3
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.印度 2826 例 COVID-19 相关的鼻-眶-脑毛霉菌病的流行病学、临床特征、治疗和结局 - 合作 OPAI-IJO 新冠病毒相关毛霉菌病研究(COSMIC),报告 1。
新型冠状病毒肺炎后遗症风险预测指标的系统评价
Cureus. 2023 Jun 21;15(6):e40717. doi: 10.7759/cureus.40717. eCollection 2023 Jun.
4
Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections.依布康唑,一种正在研发用于治疗霉菌感染的新型三萜类抗真菌药物。
J Fungi (Basel). 2022 Oct 25;8(11):1121. doi: 10.3390/jof8111121.
Indian J Ophthalmol. 2021 Jul;69(7):1670-1692. doi: 10.4103/ijo.IJO_1565_21.
4
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis.当未控制的糖尿病与重症 COVID-19 相遇:毛霉菌病的完美风暴。
J Fungi (Basel). 2021 Apr 15;7(4):298. doi: 10.3390/jof7040298.
5
Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis.COVID-19 相关肺曲霉病的发病率和死亡率:系统评价和荟萃分析。
Mycoses. 2021 Sep;64(9):993-1001. doi: 10.1111/myc.13292. Epub 2021 May 6.
6
Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature.COVID-19 感染后心脏移植受者发生毛霉菌病 - 病例报告及文献复习。
J Mycol Med. 2021 Jun;31(2):101125. doi: 10.1016/j.mycmed.2021.101125. Epub 2021 Apr 2.
7
Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.COVID-19 患者类固醇治疗期间发生的鼻眶脑毛霉病:一例报告。
Eur J Ophthalmol. 2022 Jul;32(4):NP11-NP16. doi: 10.1177/11206721211009450. Epub 2021 Apr 10.
8
Pulmonary mucormycosis: A case report.肺毛霉病:一例报告。
IDCases. 2020 Nov 1;22:e00993. doi: 10.1016/j.idcr.2020.e00993. eCollection 2020.
9
Rhino-Orbital Mucormycosis Associated With COVID-19.与新型冠状病毒肺炎相关的鼻眶毛霉病
Cureus. 2020 Sep 30;12(9):e10726. doi: 10.7759/cureus.10726.
10
Mucormycosis with orbital compartment syndrome in a patient with COVID-19.COVID-19 患者合并眼窝间隔综合征的毛霉菌病。
Am J Emerg Med. 2021 Apr;42:264.e5-264.e8. doi: 10.1016/j.ajem.2020.09.032. Epub 2020 Sep 16.